You are here

Article Text

Article menu
Download PDFPDF
Therapeutics
Review: omalizumab reduces exacerbation and steroid use in chronic asthma

https://doi.org/10.1136/ebm.12.1.11

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • For correspondence: Dr S Walker, Education for Health, Warwick, UK. S.walker{at}educationforhealth.org.uk

    • Source of funding: no external funding.